Impact of Denosumab in the Prevention of Bone Loss in Non-menopausal Women With Anorexia Nervosa
Phase of Trial: Phase III
Latest Information Update: 09 Dec 2016
At a glance
- Drugs Denosumab (Primary)
- Indications Anorexia nervosa
- Focus Therapeutic Use
- Acronyms DIBLAN
- 18 Nov 2016 Status changed from not yet recruiting to recruiting.
- 19 Apr 2016 Planned initiation date changed from 1 Dec 2015 to 1 May 2016.
- 06 Oct 2015 New trial record